Sign In
Buy OKYO
$1.55
+0.0700 (+4.73%)
At Close: Jul 24, 2026
OKYO Pharma Announces Purchase of Shares by Director
12:00pm, Thursday, 23'rd Jul 2026
LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropa
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
07:00am, Thursday, 23'rd Jul 2026
LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropa
OKYO Pharma Announces Purchase of Shares by Chairman
12:00pm, Wednesday, 22'nd Jul 2026
LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropa
OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director
10:00am, Wednesday, 22'nd Jul 2026
LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropa
OKYO Pharma Announces Purchase of Shares by Chief Medical Officer
07:00am, Wednesday, 22'nd Jul 2026
LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropa
OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
09:00am, Tuesday, 21'st Jul 2026
LONDON and NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropa
OKYO Pharma Announces Purchase of Shares by Chairman
07:00am, Tuesday, 21'st Jul 2026
LONDON and NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropa
Small caps: Replenish Nutrients, OKYO Pharma, EDM Resources
03:31pm, Monday, 20'th Jul 2026
Market breadth continues to improve, even if it has pulled back lately, according to Adam Turnquist, Chief Technical Strategist for LPL Financial.
Disney streaming margins and parks business in focus ahead of earnings
12:05pm, Monday, 20'th Jul 2026
Walt Disney Co (NYSE:DIS, XETRA:WDP) is scheduled to report fiscal third quarter results on August 5, with UBS analysts expecting accelerating earnings...
OKYO Pharma files annual report, highlights cash position and Phase 3 trial plans
08:44am, Monday, 20'th Jul 2026
OKYO Pharma Ltd (NASDAQ:OKYO) announced on Monday that it has filed its annual report on Form 20-F for the fiscal year ended March 31, 2026, with the US Securities and Exchange Commission, while outli
OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase 3 Plans
07:00am, Monday, 20'th Jul 2026
LONDON and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropa
OKYO Pharma files annual report, highlights cash position and Phase 3 trial plans
04:33am, Monday, 20'th Jul 2026
OKYO Pharma Ltd (NASDAQ:OKYO) announced on Monday that it has filed its annual report on Form 20-F for the fiscal year ended March 31, 2026, with the US...
Delta Air Lines earnings resilience supports valuation, Bank of America says
11:28am, Monday, 13'th Jul 2026
Delta Air Lines Inc (NYSE:DAL) reaffirmed its full-year earnings outlook despite higher fuel costs, a move Bank of America said underscores the carrier's...
US bank earnings could surprise to the upside as Bank of America highlights strong operating backdrop
09:27am, Monday, 13'th Jul 2026
US banks could deliver broad earnings beats as strong capital markets activity, resilient economic conditions and improving wealth management flows support...
First Hawaiian pushes into California with TriCo Bancshares deal
08:25am, Monday, 13'th Jul 2026
First Hawaiian, Inc. (NASDAQ:FHB) has agreed to acquire TriCo Bancshares (NASDAQ:TCBK), a combination the bank said will create the leading Pacific banking...
